Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.27 EUR | 0.00% |
|
-7.97% | -87.24% |
12:00am | Marinus Pharmaceuticals, Inc.(NasdaqGM:MRNS) dropped from S&P Pharmaceuticals Select Industry Index | CI |
06-17 | Sector Update: Health Care Stocks Decline Premarket Monday | MT |
Sales 2024 * | 39.35M 36.68M 53.83M | Sales 2025 * | 58.17M 54.22M 79.57M | Capitalization | 73.06M 68.1M 99.94M |
---|---|---|---|---|---|
Net income 2024 * | -119M -111M -163M | Net income 2025 * | -78M -72.7M -107M | EV / Sales 2024 * | -1.38 x |
Net cash position 2024 * | 127M 119M 174M | Net cash position 2025 * | 54.53M 50.83M 74.59M | EV / Sales 2025 * | 0.32 x |
P/E ratio 2024 * |
-0.67
x | P/E ratio 2025 * |
-1.28
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on Marinus Pharmaceuticals, Inc.
1 week | -7.97% | ||
Current month | -5.93% | ||
1 month | +1.60% | ||
3 months | -84.61% | ||
6 months | -85.49% | ||
Current year | -87.24% |
![Extreme 1.21](/images/extremecours_fleche.png)
![Extreme 1.18](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 18-09-04 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 21-04-11 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 19-11-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 08-11-30 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 18-09-04 |
Elan Ezickson
BRD | Director/Board Member | 60 | 19-12-11 |
Date | Price | Change |
---|---|---|
24-06-24 | 1.27 | 0.00% |
24-06-21 | 1.27 | -1.55% |
24-06-20 | 1.29 | -1.53% |
24-06-19 | 1.31 | 0.00% |
24-06-18 | 1.31 | -5.76% |
Real-time BOERSE MUENCHEN, June 24, 2024 at 07:44 am
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.63% | 796B | |
+41.00% | 628B | |
-5.10% | 358B | |
+19.90% | 331B | |
+9.95% | 301B | |
+17.36% | 244B | |
+3.76% | 228B | |
+12.51% | 214B | |
+6.99% | 165B |
- Stock Market
- Equities
- MRNS Stock
- 61Y Stock